Profile Picture
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • Copilot
  • More
    • Shopping
    • Flights
    • Travel
  • Notebook
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
Order byBest matchMost fresh
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days

Novo Nordisk’s oral GLP-1 drug didn’t work on Alzheimer’s

Digest more
 · 2d
Novo Nordisk says Alzheimer's trial with older GLP-1 drug fails
An older oral version of the company's semaglutide drug failed to meet its main goal in late-stage trials testing whether the medicine can slow cognitive decline in Alzheimer’s patients.

Continue reading

 · 2d · on MSN
Novo Nordisk’s oral GLP-1 drug didn’t work on Alzheimer’s as hoped, but don’t call it a failure
 · 2d · on MSN
Novo Nordisk Alzheimer's drug trials fail in blow to weight-loss giant
Investor's Business Daily on MSN
10h

Medicare Slashes Ozempic's Price Tag 71%; Why Novo Nordisk Rallied

Novo Nordisk stock jumped Wednesday on a lighter-than-feared discount for Ozempic and Wegovy under the Inflation Reduction ...
2d

Novo Nordisk Hits A 10-Year Low - I Think The Market Is Making A Mistake

Novo Nordisk's stock fell after semaglutide's Alzheimer's news. Click here for how strong fundamentals and growth catalysts ...
14h

Novo Nordisk Wants FDA Nod For A Higher-Dose Wegovy

Novo Nordisk files for FDA review of its higher-dose Wegovy after 72-week data show stronger weight loss than the current 2.4 ...
Stocktwits on MSN
5h

JPMorgan Says 2027 Medicare Drug Prices Signal Up To 40% Cuts Ahead — Novo Nordisk And Teva Stand Out As Top Targets

CMS’ newly released maximum fair prices include list-price reductions of 38% to 85% for 15 widely used medicines beginning in ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results
Feedback
  • Privacy
  • Terms